Meadows, I.; Mvungi, H.; Salim, K.; Kaswaga, O.; Mbelele, P.; Liyoyo, A.; Semvua, H.; Ngoma, A.; Heysell, S.K.; Mpagama, S.G.
N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment. Pharmaceutics 2025, 17, 516.
https://doi.org/10.3390/pharmaceutics17040516
AMA Style
Meadows I, Mvungi H, Salim K, Kaswaga O, Mbelele P, Liyoyo A, Semvua H, Ngoma A, Heysell SK, Mpagama SG.
N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment. Pharmaceutics. 2025; 17(4):516.
https://doi.org/10.3390/pharmaceutics17040516
Chicago/Turabian Style
Meadows, Idu, Happiness Mvungi, Kassim Salim, Oscar Kaswaga, Peter Mbelele, Alphonce Liyoyo, Hadija Semvua, Athumani Ngoma, Scott K. Heysell, and Stellah G. Mpagama.
2025. "N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment" Pharmaceutics 17, no. 4: 516.
https://doi.org/10.3390/pharmaceutics17040516
APA Style
Meadows, I., Mvungi, H., Salim, K., Kaswaga, O., Mbelele, P., Liyoyo, A., Semvua, H., Ngoma, A., Heysell, S. K., & Mpagama, S. G.
(2025). N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment. Pharmaceutics, 17(4), 516.
https://doi.org/10.3390/pharmaceutics17040516
